Titolo	Data di pubblicazione	Autore(i)
1	Very Elderly Patients with Chronic Phase-Chronic Myeloid Leukemia on Imatinib: No Impact of Concomitant Drugs on Complete Cytogenetic Response	2015	Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Cattaneo, D; Fava, C; Gozzini, A; Annunziata, M; Tiribelli, M; Pregno, P; Stagno, F; Vigneri, P; Cavazzini, F; Binotto, G; Mansueto, G; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Gasbarrino, C; D'Addosio, A; Cortesi, L; Cedrone, M; Rossi, Ar; Avanzini, P; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Rege-Cambrin, G; Sica, S; Luciano, L; Orlandi, Em; Bocchia, M; Tettamanti, M; Alimena, G; Saglio, G; Rosti, G; Nobili, A; Mannucci, Pm; Cortelezzi, A
2	VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY?	2015	Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A
3	[Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment]	1991	BARONI A ;AIROLDI G ;AGLIATA S ;FORTINA F ;RAGAZZONI E ;CAVAGNINO A ;DE NIGRIS A ;CAMETTI G ;FERRERO D ;FORTINA A
4	The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib	2018	Crisà, Elena; Cilloni, Daniela; Elli, Elena M.; Martinelli, Vincenzo; Palumbo, Giuseppe A.; Pugliese, Novella; Beggiato, Eloise; Frairia, Chiara; Cerrano, Marco; Lanzarone, Giuseppe; Marchetti, Monia; Mezzabotta, Mauro; Boccadoro, Mario; Ferrero, Dario
5	TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS	2016	Fava, C; Rege-Cambrin, G; Dogliotti, I; Berchialla, P; Abruzzese, E; Annunziata, M; Avanzini, P; Bergamaschi, M; Bocchia, M; Caocci, G; Catania, G; Cattaneo, D; Cavazzini, F; Cerrano, M; Chiara, E; Crugnola, M; Galimberti, S; Gambacorti-Passerini, C; Iuliano, F; Iurlo, A; Levato, L; Luciano, L; Musto, P; Orlandi, E; Pregno, P; Rapezzi, D; Russo, S; Santoro, M; Sora, F; Baccarani, M; Ferrero, D; Saglio, G.
6	Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells.	1987	Ferrero D; Pregno P; Tarella C; Ruscetti FW; Pileri A; Gallo E.
7	Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes.	1989	SEREMETIS S ;INGHIRAMI G ;FERRERO D ;NEWCOMB EW ;KNOWLES DM ;DOTTO GP ;DALLA-FAVERA R
8	Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes.	1989	Seremetis S; Inghirami G; Ferrero D; Newcomb EW; Knowles DM; Dotto GP; Dalla-Favera R.
9	The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation	2007	Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
10	Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.	1982	FERRERO D; C. TARELLA; GALLO E; RUSCETTI FW; BREITMAN TR
11	Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.	2012	Lobetti-Bodoni C; Ferrero D; Genuardi E; Passera R; Bernocco E; Sia D; Grignani G; Crisà E; Monitillo L; Rocci A; Drandi D; Giai V; Zanni M; Boi M; Isaia G; Barbero D; Lunghi M; Abruzzese E; Radaelli F; Pini M; Pregno P; Carlo-Stella C; Gaidano G; Boccadoro M; Ladetto M.
12	Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines	2004	Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella
13	Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.	2014	Ferrero D;Crisà E;Marmont F;Audisio E;Frairia C;Giai V;Gatti T;Festuccia M;Bruno B;Riera L;Passera R;Boccadoro M
14	Surface phenotypes of human hemopoietic progenitor cells defined by monoclonal antibodies.	1985	FERRERO D ;GABBIANELLI M ;PESCHLE C ;LANGE B ;ROVERA G
15	Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies.	1984	Lange B; Ferrero D; Pessano S; Palumbo A; Faust J; Meo P; Rovera G
16	Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: modulating effects of dihydroxylated vitamin D3, alpha interferon and 'stem cell factor'.	1997	FERRERO D ;CARLESSO N ;BRESSO P ;ROUX V ;PREGNO P ;GALLO E ;PILERI A
17	Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies.	1984	Pessano S; Palumbo A; Ferrero D; Pagliardi GL; Bottero L; Kai Lai S; Meo P; Carter C; Hubbel H; Lange B; Rovera G
18	Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.	1994	V. PIACIBELLO; F. SANAVIO; P. BRESSO; A. SEVERINO; N. CARLESSO; P. PREGNO; A. STACCHINI; S. MORELLI; L. FUBINI; E. GALLO; M. AGLIETTA; D. FERRERO
19	Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes	2003	CILLONI D; GOTTARDI E; MESSA F; FAVA M; SCARAVAGLIO P; BERTINI M; GIROTTO; M; MARINONE C; FERRERO D; GALLAMINI A; LEVIS A; G. SAGLIO
20	Sensibilita' delle sottopopolazioni staminali mieloidi (CFU-GM) a CSA di diversa origine.	1985	Gallo E; Ferrero D; Badoni R; Caracciolo D; Bellone G; Tarella C.